CORC

浏览/检索结果: 共86条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Comparative Study of the Gut Microbiota Among Four Different Marine Mammals in an Aquarium 期刊论文
Frontiers in Microbiology, 2021, 卷号: 12, 页码: 15
作者:  Bai, Shijie;  Zhang, Peijun;  Zhang, Changhao;  Du, Jiang;  Du, Xinyi
收藏  |  浏览/下载:0/0  |  提交时间:2021/12/23
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载:56/0  |  提交时间:2019/12/05
Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results 期刊论文
HEPATOLOGY INTERNATIONAL, 2019, 卷号: 13, 期号: 3
作者:  Liang, Xieer;  Gao, Zhiliang;  Xie, Qing;  Zhang, Jiming;  Sheng, Jifang
收藏  |  浏览/下载:45/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:44/0  |  提交时间:2019/12/05
An improved technique for measuring piston-assembly friction and comparative analysis with numerical simulations: Under motored condition 期刊论文
Mechanical Systems and Signal Processing, 2019, 卷号: 115, 页码: 657-676
作者:  Fang, Congcong;  Meng, Xianghui*;  Xie, Youbai;  Wen, Chengwei;  Liu, Ruichao
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/03
In situ hydrothermal etching fabrication of CaTiO3 on TiO2 nanosheets with heterojunction effects to enhance CO2 adsorption and photocatalytic reduction 期刊论文
CATALYSIS SCIENCE & TECHNOLOGY, 2019, 卷号: 9, 页码: 336-346
作者:  Lin, Jinjin;  Hu, Jiangshan;  Qiu, Chengwei;  Huang, Huijuan;  Chen, Lu
收藏  |  浏览/下载:9/0  |  提交时间:2019/11/21
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:34/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:36/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:32/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:29/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace